The table below shows LIGAND PHARMACEUTICALS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$268.09M
$167.13M
$131.31M
$196.25M
$241.54M
$163.56M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$81.18M
$21.43M
$24.54M
$36.08M
$32.10M
$40.50M
SG&A
LGND annual revenue (10-K history)
LIGAND PHARMACEUTICALS INC reported annual revenue of $268.09M for fiscal year 2025. That is up 60.4% from $167.13M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $108.97M (FY 2016) to $268.09M. Figures come from the company's audited annual reports as filed with the SEC.